Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cells for Bronchopulmonary Dysplasia
NCT03683953Phase 1Unknown
- Sponsor
- Guangdong Women and Children Hospital
- Start
- Sep 2018
- Primary completion
- Aug 2019
- Modality
- Stem Cell Therapies
01
Overview
Phase 1, randomised, double-blind trial in bronchopulmonary dysplasia (BPD) comparing Mesenchymal Stem Cells with Placebo (2 arms). Primary endpoint: Number of patients with BPD after instillation mesenchymal stem cells. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT03683953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03683953.